UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read Moreby Emily Kimber | Apr 23, 2025 | News | 0
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read Moreby Jen Brogan | Aug 12, 2024 | News | 0
Bowel cancer was the most common cancer to be identified in both men and women
Read Moreby Jen Brogan | Aug 9, 2024 | News | 0
In the UK, there are an estimated 11 million people living with a neurological condition
Read Moreby Jen Brogan | Aug 7, 2024 | News | 0
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Read Moreby Jen Brogan | Jul 26, 2024 | News | 0
Researchers predicted the onset of 67 diseases, out-performing current standard models
Read Moreby Jen Brogan | Jul 25, 2024 | News | 0
The research will help to better understand how this pathway is coordinated in the cell
Read Moreby Jen Brogan | Jul 24, 2024 | News | 0
The neurodegenerative disease is currently the most common cause of dementia
Read Moreby Jen Brogan | Jul 18, 2024 | News | 0
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Read Moreby Jen Brogan | Jul 10, 2024 | News | 0
The neurodegenerative condition currently affects more than 944,000 people in the UK
Read Moreby Jen Brogan | Jul 3, 2024 | News | 0
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Read Moreby Jen Brogan | Jun 27, 2024 | News | 0
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
Read Moreby Jen Brogan | Jun 19, 2024 | News | 0
Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479